Abrogation of surgery-induced decline in circulating dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/11037053

Download in:

View as

General Info

PMID
11037053